TrialJournal of the American Heart Association2022

Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY.

Antonio Brucato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.